Evidence map›Paper›PMID 35070171›Full record

ArticleComputational and structural biotechnology journal2022

Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts.

Zihang Zeng, Yanping Gao, Jiali Li, Gong Zhang, Shaoxing Sun, Qiuji Wu, Yan Gong, Conghua Xie

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Multisystem failure, tipping points, and risk of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Article
  6. Cancers · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zihang ZengDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yanping GaoDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jiali LiDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Gong ZhangDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Shaoxing SunDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Qiuji WuDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yan GongDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
Conghua XieDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCox proportional hazard regression (CPH) model relies on the proportional hazard (PH) assumption: the hazard of variables is independent of time. CPH has been widely used to identify prognostic markers of the transcriptome. However, the comprehensive investigation on PH assumption in transcriptomic data has lacked.

resultsThe whole transcriptomic data of the 9,056 patients from 32 cohorts of The Cancer Genome Atlas and the 3 lung cancer cohorts from Gene Expression Omnibus were collected to construct CPH model for each gene separately for fitting the overall survival. An average of 8.5% gene CPH models violated the PH assumption in TCGA pan-cancer cohorts. In the gene interaction networks, both hub and non-hub genes in CPH models were likely to have non-proportional hazards. Violations of PH assumption for the same gene models were not consistent in 5 non-small cell lung cancer datasets (all kappa coefficients < 0.2), indicating that the non-proportionality of gene CPH models depended on the datasets. Furthermore, the introduction of log(t) or sqrt(t) time-functions into CPH improved the performance of gene models on overall survival fitting in most tumors. The time-dependent CPH changed the significance of log hazard ratio of the 31.9% gene variables.

conclusionsOur analysis resulted that non-proportional hazards should not be ignored in transcriptomic data. Introducing time interaction term ameliorated performance and interpretability of non-proportional hazards of transcriptome data in CPH.

Indexed as

ACC, Adrenocortical carcinomaAIC, Akaike information criterionBLCA, Bladder Urothelial CarcinomaBRCA, Breast invasive carcinomaCESC, Cervical squamous cell carcinoma and endocervical adenocarcinomaCHOL, CholangiocarcinomaCOAD, Colon adenocarcinomaCON, Concordance regressionCox regressionCPH, Cox proportional hazard regressionDLBC, Lymphoid Neoplasm Diffuse Large B-cell LymphomaESCA, Esophageal carcinomaGBM, Glioblastoma multiformeGEO, Gene Expression OmnibusGO, Gene OntologyHNSC, Head and Neck squamous cell carcinomaKICH, Kidney ChromophobeKIRC, Kidney renal clear cell carcinomaKIRP, Kidney renal papillary cell carcinomaLGG, Brain Lower Grade GliomaLIHC, Liver hepatocellular carcinomaLUAD, Lung adenocarcinomaLUSC, Lung squamous cell carcinomaMESO, MesotheliomaOS, overall survivalOV, Ovarian serous cystadenocarcinomaPAAD, Pancreatic adenocarcinomaPan-cancerPCPG, Pheochromocytoma and ParagangliomaPH, proportional hazardPRAD, Prostate adenocarcinomaProportional hazard assumptionREAD, Rectum adenocarcinomaSARC, SarcomaSKCM, Skin Cutaneous MelanomaSTAD, Stomach adenocarcinomaTCGATCGA, The Cancer Genome AtlasTCGA, tumor abbreviationsTGCT, Testicular Germ Cell TumorsTHCA, Thyroid carcinomaTHYM, ThymomaTranscriptomeUCEC, Uterine Corpus Endometrial CarcinomaUCS, Uterine CarcinosarcomaUVM, Uveal Melanoma

Identifiers

PMID35070171
PMCPMC8762368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.